News

NET4CGD News  : First CGD patient to be treated - Dana-Farber/Boston Children’s Gene Therapy Programme.

On December 18, 2015, 22-year-old Brenden Whittaker became the first CGD patient to be treated with gene therapy for chronic granulomatous disease (CGD) - Dana-Farber/Boston Children’s Gene Therapy Programme.

Further information can be found on the Boston Children's Hospital website by clicking here.